Literature DB >> 14980551

Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling.

Matthew Liptrot1, Karen H Adams, Lars Martiny, Lars H Pinborg, Markus N Lonsdale, Niels V Olsen, Søren Holm, Claus Svarer, Gitte M Knudsen.   

Abstract

In emission tomography, quantification of brain tracer uptake, metabolism or binding requires knowledge of the cerebral input function. Traditionally, this is achieved with arterial blood sampling. We propose a noninvasive alternative via the use of a blood vessel time-activity curve (TAC) extracted directly from dynamic positron emission tomography (PET) scans by cluster analysis. Five healthy subjects were injected with the 5HT(2A)-receptor ligand [(18)F]-altanserin and blood samples were subsequently taken from the radial artery and cubital vein. Eight regions-of-interest (ROI) TACs were extracted from the PET data set. Hierarchical K-means cluster analysis was performed on the PET time series to extract a cerebral vasculature ROI. The number of clusters was varied from K = 1 to 10 for the second of the two-stage method. Determination of the correct number of clusters was performed by the 'within-variance' measure and by 3D visual inspection of the homogeneity of the determined clusters. The cluster-determined input curve was then used in Logan plot analysis and compared with the arterial and venous blood samples, and additionally with one of the currently used alternatives to arterial blood sampling, the Simplified Reference Tissue Model (SRTM) and Logan analysis with cerebellar TAC as an input. There was a good agreement (P < 0.05) between the values of Distribution Volume (DV) obtained from the K-means-clustered input function and those from the arterial blood samples. This work acts as a proof-of-principle that the use of cluster analysis on a PET data set could obviate the requirement for arterial cannulation when determining the input function for kinetic modelling of ligand binding, and that this may be a superior approach as compared to the other noninvasive alternatives.

Mesh:

Substances:

Year:  2004        PMID: 14980551     DOI: 10.1016/j.neuroimage.2003.09.058

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  20 in total

1.  An input function estimation method for FDG-PET human brain studies.

Authors:  Hongbin Guo; Rosemary A Renaut; Kewei Chen
Journal:  Nucl Med Biol       Date:  2007-07       Impact factor: 2.408

Review 2.  Image-derived input function for brain PET studies: many challenges and few opportunities.

Authors:  Paolo Zanotti-Fregonara; Kewei Chen; Jeih-San Liow; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-03       Impact factor: 6.200

3.  A method for generating image-derived input function in quantitative 18F-FDG PET study based on the monotonicity of the input and output function curve.

Authors:  Shan Zhou; Kewei Chen; Eric M Reiman; De-min Li; Baoci Shan
Journal:  Nucl Med Commun       Date:  2012-04       Impact factor: 1.690

Review 4.  Quantitative assessment of dynamic PET imaging data in cancer imaging.

Authors:  Mark Muzi; Finbarr O'Sullivan; David A Mankoff; Robert K Doot; Larry A Pierce; Brenda F Kurland; Hannah M Linden; Paul E Kinahan
Journal:  Magn Reson Imaging       Date:  2012-07-21       Impact factor: 2.546

5.  3.5D dynamic PET image reconstruction incorporating kinetics-based clusters.

Authors:  Lijun Lu; Nicolas A Karakatsanis; Jing Tang; Wufan Chen; Arman Rahmim
Journal:  Phys Med Biol       Date:  2012-08-07       Impact factor: 3.609

Review 6.  Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.

Authors:  Peter Brust; Jörg van den Hoff; Jörg Steinbach
Journal:  Neurosci Bull       Date:  2014-08-29       Impact factor: 5.203

Review 7.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 8.  Methodological considerations in quantification of oncological FDG PET studies.

Authors:  Dennis Vriens; Eric P Visser; Lioe-Fee de Geus-Oei; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-20       Impact factor: 9.236

9.  Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function.

Authors:  F O'Sullivan; J Kirrane; M Muzi; J N O'Sullivan; A M Spence; D A Mankoff; K A Krohn
Journal:  IEEE Trans Med Imaging       Date:  2009-08-25       Impact factor: 10.048

10.  Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.

Authors:  Asma Bashir; Mark Bitsch Vestergaard; Tina Binderup; Helle Broholm; Lisbeth Marner; Morten Ziebell; Kåre Fugleholm; Tiit Mathiesen; Andreas Kjær; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.